Definitive Contract W15QKN21C0012
Award Date
12/22/20
Potential Completion Date
6/30/23
Potential Value
$11B
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Picatinny
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,859,517,906.00 firm fixed-price definitive contract awarded by the Bureau for Global Health, a civilian agency within the U.S. government, to Pfizer Inc. for the provision of COVID-19 vaccines for international donation. The contract has an ultimate completion date of February 29, 2024 and does not utilize any set-aside designations. Pfizer is the prime contractor for this award, which is associated with the company's existing Vaccines for Children (VFC) program contract with the...
This is a $12,549,999,847.50 Definitive Contract awarded by the U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division on behalf of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) and the Biomedical Advanced Research and Development Authority (BARDA) to Pfizer Inc. for the delivery of 10 million treatment courses of the oral protease inhibitor PF-07321332. This contract, which does not utilize a small business...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,129.80 and a period of performance ending on March 18, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
<p>The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense (DOD - Army - USASC) awarded an $8.66 billion definitive contract to Pfizer Inc., doing business as Pfizer, for COVID-19 Adult MDV Vaccine. The contract is a firm fixed price agreement with a place of performance in New York, NY. The period of performance spans from June 29, 2022 through February 29, 2024. No subcontractors were identified.</p>
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical products. The $11,357.70 firm fixed-price contract has an ultimate completion date of October 10, 2024. The award is likely part of a larger indefinite delivery contract the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a $1,100.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Pfizer COVID-19 vaccine doses to support healthcare requirements from 2024 to 2025, including an initial 6-month period and up to a 4-year extension. This order is not associated with a set-aside program and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines. The contract has a ceiling value of $1,100.15 and a period of performance through May 8, 2025. It is not designated as a set-aside contract, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA Troop...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The award, with a ceiling value of $1,135.77, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the supply of 0.9 mL doses of the Pfizer COVID-19 vaccine over a period of 6 months to 4 years, with an ultimate completion date...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines for the years 2024-2025, with a contract ceiling value of $2,271.56. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. The contract supports the federal government's ongoing COVID-19 vaccination efforts, providing 0.9 mL...
This is a $21,841.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of 0.9ML Pfizer COVID-19 vaccines for the 2024-2025 time period under an Existing Use Authorization (EUA). The contract has an ultimate completion date of September 11, 2024. It is not designated as a set-aside contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...